These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8892091)

  • 1. Analysis of naturally processed peptides eluted from HLA DRB1*0402 and *0404.
    Hayden JB; McCormack AL; Yates JR; Davey MP
    J Neurosci Res; 1996 Sep; 45(6):795-802. PubMed ID: 8892091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
    J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
    Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif.
    Wymann D; Blüggel M; Kalbacher H; Blesken T; Akdis CA; Meyer HE; Blaser K
    Immunology; 1999 Jan; 96(1):1-9. PubMed ID: 10233671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
    J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets.
    Lippolis JD; White FM; Marto JA; Luckey CJ; Bullock TN; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 2002 Nov; 169(9):5089-97. PubMed ID: 12391225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of complexes of major histocompatibility class II molecules and known antigenic peptide by metal chelate affinity chromatography.
    Nag B; Mukku PV; Arimilli S; Kendrick T; Deshpande SV; Sharma SD
    J Immunol Methods; 1994 Mar; 169(2):273-85. PubMed ID: 7510762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and rapid identification of an abundant self-peptide from class II HLA-DRB1*0401 alleles induced by measles vaccine virus infection.
    Ovsyannikova IG; Johnson KL; Naylor S; Poland GA
    J Immunol Methods; 2000 Dec; 246(1-2):1-12. PubMed ID: 11121542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
    Monji T; McCormack AL; Yates JR; Pious D
    J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
    Appella E; Padlan EA; Hunt DF
    EXS; 1995; 73():105-19. PubMed ID: 7579970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development.
    Patarroyo ME; Cifuentes G; Baquero J
    Immunogenetics; 2006 Jul; 58(7):598-606. PubMed ID: 16791622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.
    Ovsyannikova IG; Johnson KL; Muddiman DC; Vierkant RA; Poland GA
    J Virol; 2004 Jan; 78(1):42-51. PubMed ID: 14671086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
    Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
    Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.
    Hofmann S; Glückmann M; Kausche S; Schmidt A; Corvey C; Lichtenfels R; Huber C; Albrecht C; Karas M; Herr W
    Mol Cell Proteomics; 2005 Dec; 4(12):1888-97. PubMed ID: 16112985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.
    Verreck FA; Elferink D; Vermeulen CJ; Amons R; Breedveld F; de Vries RR; Koning F
    Tissue Antigens; 1995 Apr; 45(4):270-5. PubMed ID: 7638864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.